摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-Dihydro-5,5-bis(hydroxymethyl)-3-methyl-1,4-oxazin-2-one | 86528-00-9

中文名称
——
中文别名
——
英文名称
5,6-Dihydro-5,5-bis(hydroxymethyl)-3-methyl-1,4-oxazin-2-one
英文别名
3,3-bis(hydroxymethyl)-5-methyl-2H-1,4-oxazin-6-one
5,6-Dihydro-5,5-bis(hydroxymethyl)-3-methyl-1,4-oxazin-2-one化学式
CAS
86528-00-9
化学式
C7H11NO4
mdl
——
分子量
173.169
InChiKey
RFQFTHBUFCKSBO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.8
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    79.1
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,6-Dihydro-5,5-bis(hydroxymethyl)-3-methyl-1,4-oxazin-2-one异丙醇 作用下, 以 乙酸乙酯 为溶剂, 反应 55.0h, 以25%的产率得到Bi(5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl)
    参考文献:
    名称:
    Bi[5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl] (BHM-3 dimer). A low toxicity, water-soluble, one-electron reducing agent
    摘要:
    Bi[5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl] (BHM-3 dimer) was synthesized by condensing tris(hydroxymethyl)aminomethane with ethyl pyruvate to form 5,6-dihydro-5,5-bis-(hydroxymethyl)-3-methyl-1,4-oxazin-2-one (1) followed by photoreduction in 2-propanol. BHM-3 dimer exists in equilibrium with 5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl (BHM-3) in solution; the rate constant for BHM-3 formation from dimers varies with solvent increasing from 5.3 x 10(-6) s-1 in acetonitrile to 1.5 x 10(-3) s-1 in water at 25-degrees-C. BHM-3 reacts as a one-electron reducing agent, and the reduction potential for BHM-3 dimer is estimated at -0.54 V vs NHE from the position of equilibrium for the reduction of the viologen, propyldiquat, to its radical cation. BHM-3 dimer has an octanol/water partition coefficient of 0.054 and shows low mouse toxicity even upon intravenous administration. Intravenously administered BHM-3 dimer projects mice from an immediated subsequent lethal injection of the antitumor drug adriamycin. The properties of BHM-3 dimer are compared with those of other 2-oxomorpholin-3-yl dimers.
    DOI:
    10.1021/jo00078a011
  • 作为产物:
    描述:
    5,5-Bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl 在 三羟甲基氨基甲烷盐酸盐三羟甲基氨基甲烷 、 paraquat 作用下, 以 甲醇乙腈 为溶剂, 生成 5,6-Dihydro-5,5-bis(hydroxymethyl)-3-methyl-1,4-oxazin-2-one
    参考文献:
    名称:
    Bi[5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl] (BHM-3 dimer). A low toxicity, water-soluble, one-electron reducing agent
    摘要:
    Bi[5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl] (BHM-3 dimer) was synthesized by condensing tris(hydroxymethyl)aminomethane with ethyl pyruvate to form 5,6-dihydro-5,5-bis-(hydroxymethyl)-3-methyl-1,4-oxazin-2-one (1) followed by photoreduction in 2-propanol. BHM-3 dimer exists in equilibrium with 5,5-bis(hydroxymethyl)-3-methyl-2-oxomorpholin-3-yl (BHM-3) in solution; the rate constant for BHM-3 formation from dimers varies with solvent increasing from 5.3 x 10(-6) s-1 in acetonitrile to 1.5 x 10(-3) s-1 in water at 25-degrees-C. BHM-3 reacts as a one-electron reducing agent, and the reduction potential for BHM-3 dimer is estimated at -0.54 V vs NHE from the position of equilibrium for the reduction of the viologen, propyldiquat, to its radical cation. BHM-3 dimer has an octanol/water partition coefficient of 0.054 and shows low mouse toxicity even upon intravenous administration. Intravenously administered BHM-3 dimer projects mice from an immediated subsequent lethal injection of the antitumor drug adriamycin. The properties of BHM-3 dimer are compared with those of other 2-oxomorpholin-3-yl dimers.
    DOI:
    10.1021/jo00078a011
点击查看最新优质反应信息

文献信息

  • Substituent effects on the formation of aminocarboxy-type capto-dative free radicals
    作者:Richard J. Himmelsbach、Anthony D. Barone、Don L. Kleyer、Tad H. Koch
    DOI:10.1021/jo00166a010
    日期:1983.9
查看更多

同类化合物

乙基6H-1,2-恶嗪-3-羧酸酯 6-乙氧基-6H-1,2-恶嗪-3-甲醛 6-乙氧基-3-苯基-6H-1,2-恶嗪 5-甲氧基-3,6-二氢-2H-[1,4]恶嗪 5-乙氧基-3,6-二氢-2H-1,4-恶嗪 5,6-二氢-2H-1,4-恶嗪-3-胺 4H-1,4-恶嗪 4-(叔丁氧羰基)-4H-[1,4]恶嗪 3H-咪唑并[2,1-c][1,4]恶嗪 3-甲基-5-苯基-2H-1,4-恶嗪 3,5-二苯基-2H-1,4-恶嗪 3,5,5,6-四甲基-5,6-二氢-2H-1,4-恶嗪-2-酮 2H-[1,4]恶嗪并[3,4-b][1,3]恶嗪 2H-1,4-恶嗪 2H-1,4-噁嗪-2-酮,5,6-二氢-5-(1-甲基乙基)-3-苯基-,(S)- 2H-1,4-噁嗪-2-酮,3-(1,1-二甲基乙基)-5,6-二氢-5-苯基-,(R)- 2H-1,3-恶嗪 2H-1,2-恶嗪 2-异丙基-4,4,6-三甲基-4H-1,3-恶嗪 2-(二甲基氨基)-4-苯基-4H-1,3-恶嗪-5-甲醛 2,4,4-三(三氟甲基)-6-全氟丁基-1,3,5-恶二嗪 (5S)-5,6-二氢-6,6-二甲基-5-苯基-2H-1,4-恶嗪-2-酮 3-(triethylsilyl)-2,5-dihydrofuran 4,4,6-trimethyl-2-propyl-4H-[1,3]oxazine 3-methyl-6,7,8,8a-tetrahydro-5H-cyclohepta[d]isoxazole 2,4-Dicyan-6-methyl-1,3-oxazepin 2,4-Dicyan-1,3-oxazepin 4-tert-Butyl-2,4,6-trimethyl-4H-pyran 3-(4,4,6-trimethyl-4H-[1,3]oxazin-2-yl)-propionitrile 4,4,6-Trimethyl-2-isopropenyl-1,3,4-oxazin 4a,7a-dihydro-4a,6-dimethyl-3-phenyl-4H-furo<2,3-e>-1,2-oxazine 3-methyl-1,4,6,9-tetraoxa-2-aza-5λ5-phospha-spiro[4.4]non-2-ene 6,8-Diethyl-1,1,2,2,3,3-hexafluoro-5-oxa-7,9-diaza-spiro[3.5]nona-6,8-diene (R)-4-Ethyl-3-((4S,5S)-4-methoxymethyl-5-phenyl-4,5-dihydro-oxazol-2-yl)-4H-pyridine-1-carboxylic acid methyl ester 4-Phenyl-2-pyrrolidin-1-yl-4,5-dihydro-furan-3-carbonitrile (S)-4-Ethyl-3-((4S,5S)-4-methoxymethyl-5-phenyl-4,5-dihydro-oxazol-2-yl)-4H-pyridine-1-carboxylic acid methyl ester (3S)-5-methyl-3-propan-2-yl-2,3-dihydro-1,4-oxazin-6-one dimethyl[η(10)-2,4-cyclopentadien-1-ylidene(dimethylsilylene)(3,4-di-tert-butyl-2,4-cyclopentadien-1-ylidene)]zirconium tert-butoxymethyl[η(10)-2,4-cyclopentadien-1-ylidene(dimethylsilylene)(3,4-di-tert-butyl-2,4-cyclopentadien-1-ylidene)]zirconium 2-Trimethylsilyl-4-methyl-4H-pyran methyl 3-methyl-6-trimethylsilylcyclohexa-1,4-dienecarboxylate 5-methyl-3-phenyl-(3ar,6ac)-3a,6a-dihydro-furo[2,3-d]isoxazole 2-methyl-4-chloro-3,6-dihydro-1,2-oxazine 4-n-butyl-3-<(N,N-diethylamino)methyl>-4,6-dimethyl-4H-pyran 3,5-diphenyl-(3ar,4at,7at,9ac)-3a,4a,7a,9a-tetrahydro-cyclohepta[2,1-d;4,5-d']diisoxazol-4-one 2-methyl-5-chloro-3,6-dihydro-1,2-oxazine 4,4-Di-tert-butyl-3-methyl-4H-<1,2>oxazet-N-oxid 6H-Pyrano[3,4-c]pyridine 6-ethoxy-3-phenyl-4-(trimethylsilylethynyl)-6H-1,2-oxazine 5,5-Dimethyl-2-oxazolin-4-spiro-3'-(1'-pyrrolin)